Correlation Between 23Andme Holding and Coeptis Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Coeptis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Coeptis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Coeptis Therapeutics Holdings, you can compare the effects of market volatilities on 23Andme Holding and Coeptis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Coeptis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Coeptis Therapeutics.

Diversification Opportunities for 23Andme Holding and Coeptis Therapeutics

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between 23Andme and Coeptis is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Coeptis Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeptis Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Coeptis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeptis Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Coeptis Therapeutics go up and down completely randomly.

Pair Corralation between 23Andme Holding and Coeptis Therapeutics

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Coeptis Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 10.34 times less risky than Coeptis Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Coeptis Therapeutics Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  8.22  in Coeptis Therapeutics Holdings on August 31, 2024 and sell it today you would lose (6.22) from holding Coeptis Therapeutics Holdings or give up 75.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy78.07%
ValuesDaily Returns

23Andme Holding Co  vs.  Coeptis Therapeutics Holdings

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Coeptis Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Coeptis Therapeutics Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Coeptis Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

23Andme Holding and Coeptis Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and Coeptis Therapeutics

The main advantage of trading using opposite 23Andme Holding and Coeptis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Coeptis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will offset losses from the drop in Coeptis Therapeutics' long position.
The idea behind 23Andme Holding Co and Coeptis Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules